MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Amantadine-induced negative myoclonus in a patient with Parkinson’s disease: A case report

    M. Vuong, L. Poon, A. Lee, J.R Zuzuárregui (San Francisco, CA, USA)

    Objective: To report a case of amantadine-induced negative myoclonus in a patient with Parkinson’s disease. Background: Parkinson’s disease is a progressive neurodegenerative disease that involves…
  • MDS Virtual Congress 2020

    Asymmetrical resting legs tremor induced by levosulpiride

    W. Yoon (Seoul, Republic of Korea)

    Objective: Our aim is to report unusual case of woman who presented asymmetrical resting tremor of both legs induced by levosulpiride. Background: Resting tremor of…
  • MDS Virtual Congress 2020

    Early-onset peak dose Levodopa induced dyskinesia in elderly Ethiopian Parkinson’s disease patient

    Y. Zewde (Addis Ababa, Ethiopia)

    Objective: The aim was to report an early onset peak dose dyskinesia in a 55 years old Parkinson's disease patient who was naive to treatment…
  • MDS Virtual Congress 2020

    Refractory cervical dystonia: is the infiltration of the obliquus capitis inferior muscle a game changer?

    A. Beltrán, F. Rodríguez, J.L Chico García, P. Parra, I. Pareés, J.C Martínez Castrillo, A. Alonso Cánovas, G. Sánchez (Madrid, Spain)

    Objective: To communicate the results of infiltration of obliquus capitis inferior (OCI) muscle in complex cervical dystonia (CD). Background: Treatment of CD with botulinum toxin…
  • MDS Virtual Congress 2020

    Patient experiences of cervical dystonia management with botulinum toxin A: A comparison of US versus European survey findings

    C. Comella, J. Ferreira, M. Azoulai, E. Pain, S. Om (Chicago, IL, USA)

    Objective: Evaluate differences in the botulinum neurotoxin type A (BoNT-A) treatment experience between patients with cervical dystonia (CD) treated in the United States (US) versus…
  • MDS Virtual Congress 2020

    KMT2B-related disorders: Expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation

    L. Cif, D. Demailly, J. Lin, K. Barwick, D. Steel, M. Sa, N. Dorison, D. Doummar, L. Lion François, P. Coubes, K. Gorman, M. Kurian (Pierre-Bénite, France)

    Objective: Clarifying clinical phenotype, molecular genetic features and evolution with deep brain stimulation (DBS) of KMT2B related disease. Background: Heterozygous mutations in KMT2B are associated…
  • MDS Virtual Congress 2020

    Anatomy-guided injections of Botulinum neurotoxin in neck muscles: how accurate is needle placement?

    A. Kreisler, C. Simonin, A. Degardin, E. Mutez, L. Defebvre (Lille, France)

    Objective: To assess the accuracy of anatomy-guided BoNT injections in cervical muscles. Background: Botulinum neurotoxin (BoNT) is the first line therapy for cervical dystonia; some…
  • MDS Virtual Congress 2020

    Cerebellar deep brain stimulation for secondary dystonia: A Case Report

    S.Z Lin, H.X Li, CC. Zhang, Y.H Wang, Y.W Wu, D.Y Li (Shanghai, China)

    Objective: To evaluate whether cerebellum deep brain stimulation (DBS) is effective in patient with secondary dystonia and to compare which target in cerebellum is more…
  • MDS Virtual Congress 2020

    Deep brain stimulation for generalized dystonia

    K. Szalecki, T. Kmiec, H. Koziara, T. Mandat (Warszawa, Poland)

    Objective: Objective : Author presents a group of patients with generalized dystonia treated with deep brain stimulation (DBS). Background: 32 patients (18 male, 16 female)…
  • MDS Virtual Congress 2020

    Deep Brain Stimulation (DBS) for Childhood Onset Dystonia

    D. Munoz, M. Troncoso, D. Aguirre, E. Zambrano, R. Zepeda, S. Monsalve, R. Catalan, V. Naranjo, I. Ruiz, M. Hidalgo (Santiago, Chile)

    Objective: The aim of this study is to quantify DBS treatment outcome in patient with chilhood onset dystonia between the years 2014-2020. Background: Deep brain stimulation (DBS)…
  • « Previous Page
  • 1
  • …
  • 764
  • 765
  • 766
  • 767
  • 768
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley